Alleycorp | Activity

Podcast

Kevin Ryan joined The Tim Ferriss Show covering DoubleClick's early days, Transcend Therapeutics sale, AlleyCorp's investment strategy, and top performing portfolio companies.

Alley Corp

Alley CorpAlleycorp

alleycorp.substack.comOCT 9, 2026

OCT 9, 2026

Team Change

AlleyCorp hired Lucy Goldfarb (investor, from Lead Edge Capital/Summit Partners), Gabriella Christopherson (Head of Hospitality & Building Operations), and Victoria Hu (Events Manager at The AlleyCorp Building).

Alley Corp

Alley CorpAlleycorp

alleycorp.substack.comOCT 9, 2026

OCT 9, 2026

Investment

AlleyCorp teamed up with founder Andy Moye and A-Squared Ventures to launch Glidepath Health, a platform for cell and gene therapy logistics. Exclusive license with Memorial Sloan Kettering Cancer Center.

Glidepath Health

Glidepath Health Alleycorp

alleycorp.substack.comSEP 2026

SEP 2026

Investment

AlleyCorp led Neno's €6.6M Seed Round with participation from Motive Partners and Firstminute Capital. Neno is building an AI-native financial services platform for European SMEs.

Neno

Neno Alleycorp

alleycorp.substack.comSEP 2026

SEP 2026

Investment

AlleyCorp led Epsilon Health's $27.6M financing. Epsilon is an AI-native radiology practice combining AI with physician oversight to expand radiologist capacity.

Epsilon Health

Epsilon Health Alleycorp

alleycorp.substack.comSEP 2026

SEP 2026

Investment

AlleyCorp led Avatar Robotics' $6.5M Seed Round with participation from Defy.vc, Headline, Henry Ford III. Avatar combines robotics, remote human operators, and AI for warehouse automation.

Avatar Robotics

Avatar Robotics Alleycorp

alleycorp.substack.comAUG 2026

AUG 2026

Team Change

AlleyCorp hired Bree Piperwilliams as Events Manager. Previously Head of Events at Manifest and led strategic operations at Munich Re Ventures.

Alley Corp

Alley CorpAlleycorp

alleycorp.substack.comJUL 15, 2026

JUL 15, 2026

New Fund

AlleyCorp closed Fund II at $335M, up from the $250M Fund I raised three years prior. The fund will continue focusing on early-stage investments across healthcare, enterprise/software, and deep tech.

Alley Corp

Alley CorpAlleycorp

alleycorp.substack.comJUL 15, 2026

JUL 15, 2026

New Fund

Closed a new $335M fund, up from the $250M debut fund raised in 2024, continuing an early-stage-focused, non-mega-round strategy.

AlleyCorp Fund II ($335M)

Alleycorp

alleycorp.substack.comJUL 15, 2026 fortune.com

JUL 15, 2026

Investment

AlleyCorp co-led Pathway Labs' $8.5M Seed Round alongside Breyer Capital. Pathway Labs developed EchoNext, an FDA-approved AI model for detecting structural heart disease via echocardiograms.

Pathway Labs

Pathway Labs Alleycorp

alleycorp.substack.comJUN 2026

JUN 2026

Investment

AlleyCorp led Queue's $12.6M Seed Round. Queue has built the world's first fully autonomous robotic pharmacy.

Queue

Queue Alleycorp

alleycorp.substack.comJUN 2026

JUN 2026

Investment

AlleyCorp co-led Vanna Health's $17M funding round alongside a national healthcare insurance company. Vanna Health deploys a tech-enabled model for treating serious mental illness.

Vanna Health

Vanna Health Alleycorp

alleycorp.substack.comJUN 2026

JUN 2026

Exit

Portfolio company RippleMatch was acquired by JobGet, expanding its AI-powered hiring platform into early-career recruiting.

Ripplematch

Ripplematch Alleycorp

prnewswire.comMAY 28, 2026

MAY 28, 2026

Milestone

Portfolio company Thyme Care reached unicorn status ($1B+ valuation), three years after AlleyCorp's initial investment.

Thyme Care

Thyme Care Alleycorp

tracxn.com

Added recently

Alleycorp Activity

Kevin Ryan joined The Tim Ferriss Show covering DoubleClick's early days, Transcend Therapeutics sale, AlleyCorp's investment strategy, and top performing portfolio companies.

AlleyCorp hired Lucy Goldfarb (investor, from Lead Edge Capital/Summit Partners), Gabriella Christopherson (Head of Hospitality & Building Operations), and Victoria Hu (Events Manager at The AlleyCorp Building).

AlleyCorp teamed up with founder Andy Moye and A-Squared Ventures to launch Glidepath Health, a platform for cell and gene therapy logistics. Exclusive license with Memorial Sloan Kettering Cancer Center.

AlleyCorp led Neno's €6.6M Seed Round with participation from Motive Partners and Firstminute Capital. Neno is building an AI-native financial services platform for European SMEs.

AlleyCorp led Epsilon Health's $27.6M financing. Epsilon is an AI-native radiology practice combining AI with physician oversight to expand radiologist capacity.

AlleyCorp led Avatar Robotics' $6.5M Seed Round with participation from Defy.vc, Headline, Henry Ford III. Avatar combines robotics, remote human operators, and AI for warehouse automation.

AlleyCorp hired Bree Piperwilliams as Events Manager. Previously Head of Events at Manifest and led strategic operations at Munich Re Ventures.

AlleyCorp closed Fund II at $335M, up from the $250M Fund I raised three years prior. The fund will continue focusing on early-stage investments across healthcare, enterprise/software, and deep tech.

Closed a new $335M fund, up from the $250M debut fund raised in 2024, continuing an early-stage-focused, non-mega-round strategy.

AlleyCorp co-led Pathway Labs' $8.5M Seed Round alongside Breyer Capital. Pathway Labs developed EchoNext, an FDA-approved AI model for detecting structural heart disease via echocardiograms.

AlleyCorp led Queue's $12.6M Seed Round. Queue has built the world's first fully autonomous robotic pharmacy.

AlleyCorp co-led Vanna Health's $17M funding round alongside a national healthcare insurance company. Vanna Health deploys a tech-enabled model for treating serious mental illness.

Portfolio company RippleMatch was acquired by JobGet, expanding its AI-powered hiring platform into early-career recruiting.

Portfolio company Thyme Care reached unicorn status ($1B+ valuation), three years after AlleyCorp's initial investment.